Some studies describe CCL22 as being exclusively expressed by immune cells like macrophages [29] and DC [22,30], while others report an expression also by tumor cells, like in oral squamous cell carcinoma [31] and breast cancer [9]. Here, CCL22 is linked to oral cavity squamous cell carcinoma.